Predictors of health-related quality of life in patients with chronic liver disease

Alimentary Pharmacology and Therapeutics

Volumn 30, Issue 5, 2009, Pages 469-476

  Afendy, A ^a,b   Kallman, J B ^b   Stepanova, M ^a,b   Younoszai, Z ^a   Aquino, R D ^b   Bianchi, G ^c   Marchesini, G ^c   Younossi, Z M ^a,b  

^a BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

^b INOVA FAIRFAX HOSPITAL   (United States)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; AUTOIMMUNE HEPATITIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DEMOGRAPHY; EMOTIONAL STABILITY; FATTY LIVER; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36; SOCIAL INTERACTION;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; FEMALE; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 68249122450     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.04061.x     Document Type: Article

References (24)

1. Ong JP, Younossi ZM. Approach to the diagnosis and treatment of nonalcoholic fatty liver disease. Clinical Liver Disease 2005 4 : 617 34.
2. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of non-alcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001 121 : 91 100.
3. Younossi Z, Boparai N, Price L, Kiwi M, Guyatt G. Health-related quality of life assessment in chronic liver disease: impact of type and severity of disease. Am J Gastroenterol 2001 96 : 2199 205.
4. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. J Am Med Assoc 2002 288 : 1723 7.
5. Everhart J Digestive diseases in the United States: epidemiology and impact. NIH Publication no. 94-1447, (1):4-24 1994.
6. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Non-alcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999 116 : 1413 9.
7. Bianchi G, Loguercio C, Sgarbi D, et al. Reduced quality of life in patients with chronic hepatitis C: effects of interferon treatment. Dig Liver Dis 2000 32 : 398 405.
8. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998 27 : 209 12.
9. Bonkovsky HL, Wooley JM. Reduction in health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology 1999 29 : 264 70.
10. Ware JE, Bayliss MS, Mannocchia M, Davis GL the International Hepatitis Intervention Therapy Group. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. Hepatology 1999 30 : 550 5.
11. Younossi Z, Kallman J, Kincaid J. The effects of HCV infection and management on health-related quality of life. Hepatology 2007 45 : 806 16.
12. Bondini S, Kallman J, Dan A, et al. Health-related quality of life in patients with chronic hepatitis B. Liver Int 2007 27 : 1119 25.
13. Spiegel B, Bolus R, Han S, et al. Development and validation of a disease-targeted health-related quality of life instrument in chronic hepatitis B infection: the HBQOL.l V1.0. Hepatology 2007 46 : 113 21.
14. Spiegel B, Younossi ZM, Hayes RD, Revicki D, Robbins S, Kanwal F. The impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology 2005 41 : 790 800.
15. Gold MR, Siegel JE, Russel LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York : Oxford University Press, 1996.
16. Marchesini G, Bianchi G, Amodio P, et al. Italian Study Group for quality of life in cirrhosis. Gastroenterology 2001 120 : 170 8.
17. Wagner A, Gandek B, Aaronson NK, et al. Cross-cultural comparison of the content of SF-36 translation across fourteen countries. J Clin Epidemiol 1998 51 : 925 32.
18. Dan A, Kallman J, Wheeler A, et al. Health-related quality of life in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2007 26 : 815 20.
19. Martin LM, Sheridan MJ, Younossi ZM. The impact of liver disease on health-related quality of life: a review of the literature. Curr Gastroenterol Rep 2002 4 : 79 83.
20. Ware JE Jr. SF-36 Health Survey. Manual and Interpretation Guide. Boston : The Health Institute, New England Medical Center, 1993.
21. Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation, and norming. J Clin Epidemiol 1998 51 : 1025 36.
22. McHorney CA, Ware JE, Raczek AE. The MOS 36-item short form health survey (SF-36): II; Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993 31 : 247 63.
23. Lee WJ, Huang MT, Wang W, et al. Effects of obesity surgery on the metabolic syndrome. Arch Surg 2004 139 : 1088 92.
24. Prelipcean CC, Mihai C, Gogalniceanu P, Drug VL, Chirila N. Complicatii extrahapatice subevaluate in colestaza. [Under-evaluated extrahepatic manifestations of cholestasis]. Rev Med Chir Soc Med Nat Iasi 2006 110 : 32 7.